BioAesthetics
5 known investors
BioAesthetics develops NACgraft, a cell-free, collagen-rich nipple-areolar complex graft that a surgeon applies so the patient's own cells integrate it into living nipple and areola tissue. It targets breast cancer survivors who have undergone mastectomies and lost their nipples, operating in the biomaterials and medical device field.
BiotechMedical DevicesNew Materials
Investors · 5
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $874.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $258.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2021 | $308.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $256K |
| National Science Foundation | Phase ISTTR | 2021 | $251.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.